Among patients with BC, recurrence-free and overall survival are thought to be related to the histological grade, Ki-67 expression, the status of lymph node (LN), estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (4). This evidence concerns the gene ESR1 and breast cancer.